Wednesday, 19 June 2019

Improving Quality and Convenience of your life by introducing Behavioral Rehabilitation Market


19 June 2019 - The Global Behavioral Rehabilitation Market is anticipated to grow at a higher CAGR of 6.87% during the forecast period. Neuroscience is a highly advancing field and researchers have been constantly investigating the stroke-related cognitive effects and motor deficits. These studies are probably the basis for new treatments. However, behavioral rehabilitation is a field of correlating mental illness with levels of behavioral problems. Early phase clinical trials are also conducted to determine psychology of behavior and cognitive science.

The market is driven by increasing incidences of drug addiction, occurrence of PSD’s, and counselling. Mental health awareness is gaining a significant traction in most countries and hence NGO workshops conducted for the same. Rise in number of admission for patients with mental illness and behavioral disorders is likely to trigger the market growth in upcoming period. Increase in globalization and enlarging concept of nuclear families supplement the market growth during the forecast period.


Behavioral Rehabilitation Market

Global Behavioral Rehabilitation market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
  • Acadia Healthcare
  • Universal Health Services
  • Magellan Health
  • Psychiatric Solutions
  • CRC Health
  • Aurora Behavioral Health System
  • Behavioral Health Group
  • Haven Behavioral Healthcare
  • Springstone
  • American Addiction Centers
Strategic mergers & acquisitions among key players are likely to develop a higher market growth in the forecast period. However, dearth of professional competency and cases of fraud have been challenging the market growth. Application segment for behavioral rehabilitation market comprises substance abuse, anxiety, mood, abuse and attention deficit disorders. The market is segmented by healthcare settings into residential, outpatient and inpatient.

The market is geographically segmented into North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America is anticipated to rise at a significant CAGR during the forecast period owing to increase in awareness of mental disorders and accessibility to advanced treatment facilities.


European region is anticipated to reveal a higher traction during the estimated period owing to rising competition and availability of services at affordable prices. Change in trends and inclination towards technology is likely to propel the market growth during the forecast period.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Inpatient
  • Residential
  • Outpatient
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, (sales), market share and growth rate for each application, including
  • Anxiety Disorders
  • Mood Disorders
  • Substance Abuse Disorders
  • Personality Disorders
  • Attention Deficit Disorders

No comments:

Post a Comment

Antibody Drug Conjugate (ADC) Drug Market Size, Share, Trend & Growth till 2023

16 Aug 2019 - The global Antibody Drug Conjugate Drug Market is estimated to develop at a substantial CAGR for the duration of the predict...